Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120895) titled 'ctDNA-guided dynamic monitoring for befotertinib combined with radiotherapy in oligometastatic non-small cell lung cancer with EGFR mutations: a single-arm, multicenter, exploratory study' on March 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The Fourth Hospital of Hebei Medical University

Condition: Non-small cell lung cancer

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-03-25

Target Sample Size: Trial Group:84;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=312036

Published by HT Dig...